Systems and methods for infection control in medical implants and biological conduits using electroporation

WO2025188907A8PCT designated stage Publication Date: 2025-10-02ABLATION INNOVATIONS LLC
0 Cites 0 Cited by

Patent Information

Application Number
PCT/US2025/018590
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-03-05
Filing Date
2025-03-05
Publication Date
2025-10-02

Smart Images

  • Figure US2025018590_02102025_PF_FP_ABST
    Figure US2025018590_02102025_PF_FP_ABST
Patent Text Reader

Abstract

Systems and methods for infection prevention and treatment in biological conduits using electroporation or pulsed field ablation (PFA). The system includes an elongate member, such as a dialysis catheter, vascular access device, or peritoneal dialysis conduit, with at least one electrode positioned along, within, or around the member. A control unit applies pulsed electric fields to inhibit microbial colonization, disrupt bacterial biofilms, and alter permeability of bacterial or endothelial cells to enhance sterility' or fluid, exchange. The system may use real-time impedance monitoring, microbial detection, or fluid composition analysis to adjust electroporation parameters. Electroporation may synchronize with dialysis cycles or antimicrobial lock solutions. The method includes automated, clinician-controlled, or sensor-triggered treatments to reduce infections and improve device longevity. The system provides an alternative or augment to antibiotics, reducing the risk of drug-resistant infections while improving the longevity and safety of medical implants.
Need to check novelty before this filing date? Find Prior Art